Testing effectiveness (Phase 2)Ended earlyNCT05215951What this trial is testingOsimertinib Plus Chemotherapy in Uncommon EGFRm NSCLCWho this might be right forLung Cancer AstraZeneca 4
Not applicableStudy completedNCT07239102What this trial is testingFirmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System MetastasisWho this might be right forEGFR Positive Non-small Cell Lung CancerCentral Nervous System MetastasisLeptomeningeal Metastasis Beijing Tiantan Hospital 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT05466149What this trial is testingEfficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 InsertionWho this might be right forNSCLC Allist Pharmaceuticals, Inc. 100
Not applicableStudy completedNCT05070026What this trial is testingComparison of Inflammatory Cytokine Levels Between Single-port and Three-port Thoracoscopic Lobectomy in the Treatment of Non-small Cell Lung Cancersurgery on Perioperative Clinical Indexes、Inflammatory Reaction and Quality of Life Scores of Patients With Non-small Cell Lung CancerWho this might be right forVideo-assisted Thoracoscopic SurgeryInflammatory ReactionLife Scores Shengjing Hospital 68
Testing effectiveness (Phase 2)UnknownNCT00801385What this trial is testingSorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to ChemotherapyWho this might be right forLung Cancer Yonsei University 47
Testing effectiveness (Phase 2)Ended earlyNCT00526890What this trial is testingCarboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryWho this might be right forLung Cancer Roswell Park Cancer Institute 16
Testing effectiveness (Phase 2)Study completedNCT03322540What this trial is testingPembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)Who this might be right forLung Cancer Incyte Corporation 154
Not applicableStudy completedNCT01537991What this trial is testingISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START TrialWho this might be right forLocally Advanced Non-small Cell Lung Cancer Lisette Nixon 81
Not applicableActive Not RecruitingNCT05863052What this trial is testingAnalyzing Clinical Outcomes and Genomic Data of American Indian Patient PopulationWho this might be right forImmune Checkpoint InhibitorsMetastatic Solid TumorNonsmall Cell Lung Cancer+4 more University of Oklahoma 72
Testing effectiveness (Phase 2)WithdrawnNCT02672358What this trial is testingStudy of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLCWho this might be right forNon-Small-Cell Lung Cancer Novartis Pharmaceuticals
Early research (Phase 1)UnknownNCT05942508What this trial is testingA Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and ChemotherapyWho this might be right forLimited Stage Small Cell Lung CancerNot Progressed After First-line Chemoradiotherapy Jinming Yu 20
Testing effectiveness (Phase 2)UnknownNCT00052325What this trial is testingMistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative ChemotherapyWho this might be right forLung Cancer Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Not applicableNot Yet RecruitingNCT07310589What this trial is testingEffects of a Visual Interactive LINE Chatbot on Self-Management of EGFR-TKI Related Side Effects in Patients With Lung CancerWho this might be right forNon-Small Cell Lung Cancer National Taiwan University Hospital 178
Early research (Phase 1)Study completedNCT00734890What this trial is testingVandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLung CancerLymphomaLymphoproliferative Disorder+2 more National Institutes of Health Clinical Center (CC) 18
Testing effectiveness (Phase 2)Ended earlyNCT05219578What this trial is testingRTX-224 Monotherapy in Patients With Solid TumorsWho this might be right forNon Small Cell Lung CancerCutaneous MelanomaHead and Neck Squamous Cell Carcinoma+2 more Rubius Therapeutics 7
Not applicableStudy completedNCT04312308What this trial is testingIdentification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC PatientsWho this might be right forNon Small Cell Lung Cancer Yonsei University 100
Large-scale testing (Phase 3)Active Not RecruitingNCT03456076What this trial is testingA Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Patients With ALK Positive Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Hoffmann-La Roche 257
Testing effectiveness (Phase 2)UnknownNCT05741021What this trial is testingA Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-small Cell Lung CancerNSCLCPD-1 Shandong New Time Pharmaceutical Co., LTD 84
Testing effectiveness (Phase 2)Study completedNCT00411632What this trial is testingBATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)Who this might be right forLung Cancer M.D. Anderson Cancer Center 37
Early research (Phase 1)Study completedNCT00884598What this trial is testingCilengitide and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Lung CancerWho this might be right forBrain and Central Nervous System TumorsLung Cancer Universitätsmedizin Mannheim 19